• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HMGA1 通过介导 miR-671-5p 靶向 APC 促进透明细胞肾细胞癌的转移通过 Wnt 信号通路。

HMGA1-mediated miR-671-5p targets APC to promote metastasis of clear cell renal cell carcinoma through Wnt signaling.

机构信息

The Affiliated Xiaolan Hospital of Southern Medical University, Zhongshan, China.

Guangzhou TCM Hospital, Guangzhou, China.

出版信息

Neoplasma. 2020 Jan;67(1):46-53. doi: 10.4149/neo_2019_190217N135. Epub 2019 Nov 4.

DOI:10.4149/neo_2019_190217N135
PMID:31686521
Abstract

This study aimed to investigate the effect of miR-671-5p on metastasis of clear cell renal cell carcinoma (ccRCC) and underlying mechanism involved. The migration and invasion of ccRCC cells were determined by transwell and boyden assays in vitro and in vivo. Genes mRNA and protein expression were detected by quantitative polymerase chain reaction (qPCR) and western blot analysis, respectively. The target gene of miRNA was confirmed by luciferase reporter assays. Transcriptional regulation of miRNA by transcription factor was detected by chromatin immunoprecipitation assay (ChIP). The expression of miRNA in clinical specimens were detected by in situ hybridization (ISH). miR-671-5p promoted migration and invasion of ccRCC in vivo and in vitro. Moreover, miR-671-5p directly targeted APC to activate Wnt signaling, thus inducing the epithelial-mesenchymal transition (EMT) in ccRCC. Intriguingly, miR-671-5p expression was transcriptionally enhanced by HMGA1. Consistently, bioinformatics analysis suggested that HMGA1 was positively correlated with miR-671 expression, however, miR-671 was negatively correlated with APC. In situ hybridization analysis showed that miR-671-5p was upregulated in ccRCC compared with paracarcinoma and correlated with poor prognosis of ccRCC patients. In addition, univariate and multivariate analysis indicated that miR-671-5p expression was an independent prognostic factor for overall survival in ccRCC patients. Our data suggest that miR-671-5p is a tumor enhancer in regulating of ccRCC metastasis, and miR-671-5p may be utilized as a factor for the clinical diagnosis and prognosis of ccRCC.

摘要

本研究旨在探讨 miR-671-5p 对透明细胞肾细胞癌 (ccRCC) 转移的影响及其潜在机制。通过体外和体内的 Transwell 和 Boyden 测定来确定 ccRCC 细胞的迁移和侵袭。通过定量聚合酶链反应 (qPCR) 和 Western blot 分析分别检测基因 mRNA 和蛋白表达。通过荧光素酶报告基因实验验证 miRNA 的靶基因。通过染色质免疫沉淀分析 (ChIP) 检测 miRNA 的转录因子转录调控。通过原位杂交 (ISH) 检测 miRNA 在临床标本中的表达。miR-671-5p 促进 ccRCC 在体内和体外的迁移和侵袭。此外,miR-671-5p 直接靶向 APC 激活 Wnt 信号通路,从而诱导 ccRCC 上皮-间充质转化 (EMT)。有趣的是,miR-671-5p 的表达被 HMGA1 转录增强。生物信息学分析表明,HMGA1 与 miR-671 表达呈正相关,而 miR-671 与 APC 呈负相关。原位杂交分析显示,与癌旁组织相比,miR-671-5p 在 ccRCC 中上调,并与 ccRCC 患者的不良预后相关。此外,单因素和多因素分析表明,miR-671-5p 表达是 ccRCC 患者总生存期的独立预后因素。我们的数据表明,miR-671-5p 是调节 ccRCC 转移的肿瘤增强子,miR-671-5p 可作为 ccRCC 临床诊断和预后的因素。

相似文献

1
HMGA1-mediated miR-671-5p targets APC to promote metastasis of clear cell renal cell carcinoma through Wnt signaling.HMGA1 通过介导 miR-671-5p 靶向 APC 促进透明细胞肾细胞癌的转移通过 Wnt 信号通路。
Neoplasma. 2020 Jan;67(1):46-53. doi: 10.4149/neo_2019_190217N135. Epub 2019 Nov 4.
2
LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis.长链非编码RNA ITGB2-AS1通过调控miR-328-5p/HMGA1轴促进透明细胞肾细胞癌的进展。
Hum Cell. 2021 Sep;34(5):1545-1557. doi: 10.1007/s13577-021-00563-7. Epub 2021 Jun 25.
3
MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15.miR-212-5p 通过靶向 TBX15 抑制肾透明细胞癌细胞的恶性行为。
Eur Rev Med Pharmacol Sci. 2019 Dec;23(24):10699-10707. doi: 10.26355/eurrev_201912_19770.
4
Pseudogene HSPB1P1 contributes to renal cell carcinoma proliferation and metastasis by targeting miR-296-5p to regulate HMGA1 expression.假基因 HSPB1P1 通过靶向 miR-296-5p 调控 HMGA1 表达促进肾细胞癌增殖和转移。
Cell Biol Int. 2021 Dec;45(12):2479-2489. doi: 10.1002/cbin.11694. Epub 2021 Sep 1.
5
serves as a novel biomarker and promotes tumour progression by sponging miR-204-5p and upregulating RAB22A in clear cell renal cell carcinoma.在透明细胞肾细胞癌中作为一种新型生物标志物,通过吸附miR-204-5p和上调RAB22A来促进肿瘤进展。
Ann Med. 2021 Dec;53(1):2153-2164. doi: 10.1080/07853890.2021.2001563.
6
Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.利用 miR-32-5p 抑制透明细胞肾细胞癌转移的临床前研究:通过改变 miR-32-5p/TR4/HGF/Met 信号。
Int J Cancer. 2018 Jul 1;143(1):100-112. doi: 10.1002/ijc.31289. Epub 2018 Apr 2.
7
CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR-145-5p and regulating TBX15 expression.环状 RNA PVT1 通过海绵吸附 miR-145-5p 并调节 TBX15 表达促进肾透明细胞癌进展。
Cancer Sci. 2021 Apr;112(4):1443-1456. doi: 10.1111/cas.14814. Epub 2021 Feb 10.
8
miR-155-5p Promotes Cell Proliferation and Migration of Clear Cell Renal Cell Carcinoma by Targeting PEG3.miR-155-5p 通过靶向 PEG3 促进透明细胞肾细胞癌的细胞增殖和迁移。
Urol Int. 2021;105(9-10):906-915. doi: 10.1159/000514416. Epub 2021 Jun 30.
9
MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T.miR-182-5p 通过抑制 UBE2T 抑制肾透明细胞癌的肿瘤发生。
Hum Cell. 2022 Mar;35(2):542-556. doi: 10.1007/s13577-021-00661-6. Epub 2022 Feb 7.
10
MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4.miR-337-3p 通过调节 Capn4 抑制透明细胞肾细胞癌细胞的增殖和转移。
Cancer Biomark. 2018;23(4):515-525. doi: 10.3233/CBM-181645.

引用本文的文献

1
Complicated crosstalk between HMGA and non-coding RNAs modulates hallmarks of cancer.HMGA与非编码RNA之间复杂的相互作用调节癌症的特征。
Cancer Cell Int. 2025 Mar 7;25(1):80. doi: 10.1186/s12935-025-03713-1.
2
Establishing a prognostic model of chromatin modulators and identifying potential drug candidates in renal clear cell patients.建立染色质调节剂的预后模型并鉴定肾透明细胞患者的潜在药物候选物。
BMC Bioinformatics. 2023 Mar 20;24(1):104. doi: 10.1186/s12859-023-05229-9.
3
Research progress on the role and mechanism of miR-671 in bone metabolism and bone-related diseases.
miR-671在骨代谢及骨相关疾病中的作用与机制的研究进展
Front Oncol. 2023 Jan 11;12:1018308. doi: 10.3389/fonc.2022.1018308. eCollection 2022.
4
A review on the role of miR-671 in human disorders.miR-671在人类疾病中的作用综述。
Front Mol Biosci. 2022 Dec 5;9:1077968. doi: 10.3389/fmolb.2022.1077968. eCollection 2022.
5
High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential.高迁移率族蛋白 A1(HMGA1):结构、生物学功能和治疗潜力。
Int J Biol Sci. 2022 Jul 4;18(11):4414-4431. doi: 10.7150/ijbs.72952. eCollection 2022.
6
MicroRNA‑671‑5p inhibits cell proliferation, migration and invasion in non‑small cell lung cancer by targeting MFAP3L.微小 RNA-671-5p 通过靶向 MFAP3L 抑制非小细胞肺癌细胞增殖、迁移和侵袭。
Mol Med Rep. 2022 Jan;25(1). doi: 10.3892/mmr.2021.12546. Epub 2021 Nov 29.
7
CircRIP2 promotes NSCLC progression by sponging for miR-671-5p to regulate FOXM1 expression.环状 RNA RIP2 通过海绵吸附 miR-671-5p 调控 FOXM1 表达促进 NSCLC 进展。
Histol Histopathol. 2022 Feb;37(2):117-124. doi: 10.14670/HH-18-360. Epub 2021 Jul 22.
8
CircRNA circ_0092314 Induces Epithelial-Mesenchymal Transition of Pancreatic Cancer Cells Elevating the Expression of S100P by Sponging miR-671.环状RNA circ_0092314通过海绵化miR-671上调S100P的表达,诱导胰腺癌细胞上皮-间质转化
Front Oncol. 2021 Mar 25;11:675442. doi: 10.3389/fonc.2021.675442. eCollection 2021.
9
MicroRNA Signature in Renal Cell Carcinoma.肾细胞癌中的微小RNA特征
Front Oncol. 2020 Nov 30;10:596359. doi: 10.3389/fonc.2020.596359. eCollection 2020.
10
MiRNA-671-5p Promotes prostate cancer development and metastasis by targeting NFIA/CRYAB axis.miRNA-671-5p 通过靶向 NFIA/CRYAB 轴促进前列腺癌的发展和转移。
Cell Death Dis. 2020 Nov 3;11(11):949. doi: 10.1038/s41419-020-03138-w.